Tokyo, Japan

Tetsuji Noda

This inventor holds 2 USPTO granted patents and 6 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Yuki Gosei Kogyo Co., Ltd., Yuki Gosei Kogyo Co., Ltd.. Active years: 2019-2026.

USPTO Granted Patents = 2 

% Patents Active = 50.0


 

Average Co-Inventor Count = 2.0

ph-index = 1


Company Filing History:


Years Active: 2019-2026

Loading Chart...
Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Tetsuji Noda: Innovator in Pharmaceutical Chemistry

Introduction

Tetsuji Noda is a prominent inventor based in Tokyo, Japan. He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on acid addition salts.

Latest Patents

Noda holds a patent for an acid addition salt of 3-aminoquinuclidine, which does not exhibit deliquescence. This novel compound is recognized for its industrial utility as an intermediate in the production of medicines. The patent specifically details an acid addition salt of 3-aminoquinuclidine selected from various forms, including racemic 3-aminoquinuclidine, (R)-3-aminoquinuclidine, and (S)-3-aminoquinuclidine. The acids used in this invention include phosphoric acid, sulfuric acid, fumaric acid, terephthalic acid, oxalic acid, p-toluenesulfonic acid, and both (+)-10-camphorsulfonic acid and (−)-10-camphorsulfonic acid.

Career Highlights

Tetsuji Noda is associated with Yuki Gosei Kogyo Co., Ltd., where he continues to advance his research and development efforts. His work has been instrumental in enhancing the pharmaceutical applications of his inventions.

Collaborations

Noda collaborates with Yukiko Takeda, contributing to the innovative environment at Yuki Gosei Kogyo Co., Ltd. Their partnership exemplifies the collaborative spirit in the field of pharmaceutical research.

Conclusion

Tetsuji Noda's contributions to pharmaceutical chemistry, particularly through his patent on 3-aminoquinuclidine, highlight his role as an innovator in the industry. His work continues to influence the development of important medicinal compounds.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…